We are live on ! Find out more
KFP

Keystone Financial Planning Portfolio holdings

AUM $388M
1-Year Est. Return 16.66%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+16.66%
3 Year Est. Return
+34.06%
5 Year Est. Return
+32.93%
10 Year Est. Return
+97.12%
AUM
$299M
AUM Growth
+$4.75M
Cap. Flow
+$9.33M
Cap. Flow %
3.12%
Top 10 Hldgs %
65.3%
Holding
49
New
4
Increased
33
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$14.1M
2
IFF icon
International Flavors & Fragrances
IFF
+$6.92M
3
CL icon
Colgate-Palmolive
CL
+$687K
4
PFE icon
Pfizer
PFE
+$554K
5
XOM icon
ExxonMobil
XOM
+$351K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.65M
2
UL icon
Unilever
UL
+$6.56M
3
K
Kellanova
K
+$1.47M
4
MDT icon
Medtronic
MDT
+$867K
5
PNW icon
Pinnacle West Capital
PNW
+$55.3K

Sector Composition

Rank Sector Weight
1 Consumer Staples 8.76%
2 Technology 8.08%
3 Healthcare 7.63%
4 Utilities 7.47%
5 Industrials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
26
McDonald's
MCD
$194B
$2.79M 0.93%
9,340
-20
-0.2% -$5.81K
VYM icon
27
Vanguard High Dividend Yield ETF
VYM
$81.9B
$2.69M 0.9%
25,324
+229
+0.9% +$24K
KO icon
28
Coca-Cola
KO
$380B
$2.27M 0.76%
37,760
+172
+0.5% +$10.7K
UL icon
29
Unilever
UL
$144B
$2.15M 0.72%
36,745
-110,443
-75% -$6.56M
HLN icon
30
Haleon
HLN
$45.2B
$2.01M 0.67%
239,709
+2,692
+1% +$23K
USB icon
31
US Bancorp
USB
$100B
$2M 0.67%
60,480
+2,359
+4% +$76.2K
JNJ icon
32
Johnson & Johnson
JNJ
$643B
$1.79M 0.6%
10,830
+144
+1% +$23.2K
GSK icon
33
GSK
GSK
$108B
$1.77M 0.59%
49,771
-213,211
-81% -$7.65M
PG icon
34
Procter & Gamble
PG
$347B
$1.34M 0.45%
8,860
+1,075
+14% +$162K
SNY icon
35
Sanofi
SNY
$109B
$1.25M 0.42%
23,156
+388
+2% +$20.9K
LMT icon
36
Lockheed Martin
LMT
$134B
$962K 0.32%
2,090
-84
-4% -$39K
WBD icon
37
Warner Bros
WBD
$64.2B
$874K 0.29%
69,665
+854
+1% +$11.1K
CL icon
38
Colgate-Palmolive
CL
$74.2B
$684K 0.23%
+8,875
New +$687K
EMR icon
39
Emerson Electric
EMR
$85B
$501K 0.17%
5,547
– –
VNQ icon
40
Vanguard Real Estate ETF
VNQ
$40B
$413K 0.14%
4,942
– –
SO icon
41
Southern Company
SO
$109B
$387K 0.13%
5,508
– –
TJX icon
42
TJX Companies
TJX
$178B
$347K 0.12%
+4,092
New +$323K
ACN icon
43
Accenture
ACN
$101B
$334K 0.11%
+1,081
New +$314K
CVS icon
44
CVS Health
CVS
$140B
$316K 0.11%
4,571
– –
VTRS icon
45
Viatris
VTRS
$20.8B
$271K 0.09%
27,157
+418
+2% +$3.99K
BLK icon
46
Blackrock
BLK
$170B
$255K 0.09%
369
+15
+4% +$10K
JPM icon
47
JPMorgan Chase
JPM
$950B
$206K 0.07%
+1,413
New +$194K
K
48
DELISTED
Kellanova
K
– –
-23,313
Closed -$1.47M
MDT icon
49
Medtronic
MDT
$111B
– –
-10,754
Closed -$867K
1
2

Similar funds

RWM
Ruedi Wealth Management Champaign, Illinois $388M AUM 14.69% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return
AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WA
WP Advisors San Francisco, California $387M AUM 21.17% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return

Keystone Financial Planning's Q2 2023 Portfolio in Review

As of Q2 2023, Keystone Financial Planning held 49 positions worth $299M, up 1.6% from $294M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Keystone Financial Planning deployed $9.33M of net new capital in Q2 2023, opening 4 new positions and adding to 33 existing holdings. Its largest new stake was Colgate-Palmolive: 8,875 shares worth $684K.

By sector, the portfolio is most concentrated in Consumer Staples at 8.8% of assets, down from 11% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was GSK, an estimated $7.65M trimmed.

  • Keystone Financial Planning's largest Q2 2023 buy was Colgate-Palmolive: 8,875 shares worth $684K.
  • Keystone Financial Planning added most to Schwab US Dividend Equity ETF in Q2 2023, an estimated $14.1M increase.
  • Keystone Financial Planning's biggest Q2 2023 reduction was GSK, cutting an estimated $7.65M.
  • Keystone Financial Planning fully exited Kellanova in Q2 2023, selling an estimated $1.47M.
  • Keystone Financial Planning's ten largest holdings make up 65% of its $299M portfolio in Q2 2023.
  • Keystone Financial Planning opened 4 new positions and closed 2 in Q2 2023.
  • Keystone Financial Planning's portfolio value rose 1.6% quarter-over-quarter to $299M.

Based on Keystone Financial Planning's 13F filing for Q2 2023, filed 11 Jul 2023.